Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tipifarnib in Pediatric Recurrent or Progressive High-Grade Glioma, Medulloblastoma/PNET, or Brainstem Glioma
NCT00070525Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Nov 2003
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tipifarnib in glioma, medulloblastoma, primitive neuroectodermal tumor (PNET), brainstem glioma, sponsored by National Cancer Institute. Started Nov 2003; status: completed.
02
Drugs
tipifarnib
03
Conditions
gliomamedulloblastomaprimitive neuroectodermal tumor (PNET)brainstem glioma
Beyond the preview
Go deeper on NCT00070525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00070525.